Halozyme Therapeutics
HALO
#2412
Rank
โ‚ฌ5.75 B
Marketcap
45,22 โ‚ฌ
Share price
-3.62%
Change (1 day)
27.31%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2023 (TTM): 1,65 โ‚ฌ

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is 1,68 โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 1,43 โ‚ฌ a decrease over its 2021 EPS that were of 2,75 โ‚ฌ.

EPS history for Halozyme Therapeutics from 2002 to 2023

2005201020152020โ‚ฌ1โ‚ฌ2โ‚ฌ30companiesmarketcap.com

Annual EPS

Year EPS Change
2023 (TTM)1,65 โ‚ฌ15.42%
20221,43 โ‚ฌ-48.07%
20212,75 โ‚ฌ196.88%
20200,93 โ‚ฌ-292%
2019-0,48 โ‚ฌ-9.09%
2018-0,53 โ‚ฌ-237.5%
20170,39 โ‚ฌ-149.38%
2016-0,78 โ‚ฌ211.54%
2015-0,25 โ‚ฌ-52.73%
2014-0,53 โ‚ฌ-24.66%
2013-0,70 โ‚ฌ48.98%
2012-0,47 โ‚ฌ145%
2011-0,19 โ‚ฌ-64.29%
2010-0,54 โ‚ฌ-17.65%
2009-0,66 โ‚ฌ9.68%
2008-0,60 โ‚ฌ93.75%
2007-0,31 โ‚ฌ33.33%
2006-0,23 โ‚ฌ-4%
2005-0,24 โ‚ฌ-3.85%
2004-0,25 โ‚ฌ-13.33%
2003-0,29 โ‚ฌ83.59%
2002-0,16 โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-0,18 โ‚ฌ-110.92%๐Ÿ‡บ๐Ÿ‡ธ USA
5,24 โ‚ฌ 212.03%๐Ÿ‡บ๐Ÿ‡ธ USA
4,94 โ‚ฌ 194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
1,80 โ‚ฌ 6.90%๐Ÿ‡บ๐Ÿ‡ธ USA
3,07 โ‚ฌ 82.77%๐Ÿ‡ซ๐Ÿ‡ท France
13,60 โ‚ฌ 709.50%๐Ÿ‡บ๐Ÿ‡ธ USA